Arnica (arnica montana) NDC 0220-0508

NDC codes

FDA NDC Directory

Product NDC (as listed)0220-0508Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00220-0508Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0220-0508-41	00220050841	80 PELLET in 1 TUBE (0220-0508-41)Marketed from May 1, 2009
0220-0508-43	00220050843	3 TUBE in 1 PACKAGE (0220-0508-43) / 80 PELLET in 1 TUBE (0220-0508-41)Marketed from May 1, 2009

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Arnica
Generic name (nonproprietary): arnica montana
Active ingredients: Arnica montana — 30 [hp_C]/1
Dosage form: Pellet
Route: Oral
Labeler: Laboratoires Boiron
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: May 1, 2009
Listing expires: Dec 31, 2026
Identifiers: Product ID 0220-0508_471c631f-f21f-0822-e063-6394a90a73a1SPL ID 471c631f-f21f-0822-e063-6394a90a73a1SPL set ID 1ce3fd1f-24f8-491c-a0ae-087ea3d20040UNII O80TY208ZW

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400220050841 followed by a unit qualifier and the quantity

Package 00220-0508-41. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 29, 2025.

Indications (excerpt from the label)

Uses* temporarily relieves muscle pain and stiffness due to: minor injuries overexertion falls reduces symptoms of bruising such as: pain swelling discoloration

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)